Kranzler Jay D Insider Trades

Insider Trading History

Track insider trading activity for Kranzler Jay D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $198 559 shares
Last Trade
Nov 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$137 61 shares
$2.24
$0.35
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $219 620 shares
Last Trade
Sep 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.24k 497 shares
$2.50
$0.35
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $43.5 123 shares
Last Trade
Sep 27, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.2 3 shares
$2.40
$0.35
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $10.6k 30,000 shares
Last Trade
Sep 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.8k 30,000 shares
$2.46
$0.35
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $35.3k 100,000 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.78M 100,000 shares
$87.75
$0.35
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $29.9k 84,663 shares
Last Trade
Jun 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125M 10,000 shares
$12,453.75
$0.35
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $26.4k 74,663 shares
Last Trade
Aug 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.5M 10,000 shares
$6,952.50
$0.35
Avenue Therapeutics
Avenue Therapeutics ATXI
Director
Holding Value $22.9k 64,663 shares
Last Trade
Aug 07, 2018 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$57.1M 14,663 shares
$3,892.50
$0.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up